Last updated: 11/07/2018 16:56:47
Double-Blind, Double-Dummy, Randomized, Parallel-Group Comparison of the Efficacy and Safety Outcomes of Fluticasone Propionate Aqueous Nasal Spray Versus Encapsulated Loratadine Tablets Versus Placebo for Four Weeks in Subjects with Seasonal Allergic Rhinitis
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Double-Blind, Double-Dummy, Randomized, Parallel-Group Comparison of the Efficacy and Safety Outcomes of Fluticasone Propionate Aqueous Nasal Spray Versus Encapsulated Loratadine Tablets Versus Placebo for Four Weeks in Subjects with Seasonal Allergic Rhinitis
Trial description: Double-Blind, Double-Dummy, Randomized, Parallel-Group Comparison of the Efficacy and Safety Outcomes of Fluticasone Propionate Aqueous Nasal Spray Versus Encapsulated Loratadine Tablets Versus Placebo for Four Weeks in Subjects with Seasonal Allergic Rhinitis
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Cook CK, Wisniewski M, Cox F, et al. Intranasal fluticasone propionate (FP) is more effective than Loratadine (LOR) for treatment of seasonal allergic rhinitis symptoms. Allergy 1996;51(36):152 (abstract);
Nayak AS, Shulan D, Bernstein DI, et al. Intranasal fluticasone propionate (FP) is more effective than Loratadine (LOR) for treatment of seasonal allergic rhinitis symptoms. J Allergy Clin Immunol 1996;97(1):63 (abstract);
Schenkel E, Cox F, Goodwin B, et al. Patient satisfaction with seasonal allergic rhinitis therapy in a clinical trial comparing fluticasone with Loratadine. J Allergy Clin Immunol 1996;97(1):433 (abstract);
Shulan D, Reed KD, Anschuetz G, Cook C. Intranasal fluticasone propionate (FP) compared with Loratadine (LOR) in the1995 spring tree season. Ann Allergy 1996;76:96 (abstract)
Medical condition
Rhinitis, Allergic, Seasonal
Product
fluticasone propionate
Collaborators
Not applicable
Study date(s)
N/A to Invalid Date
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
Not applicable
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website